{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T05:14:12Z","timestamp":1768713252161,"version":"3.49.0"},"reference-count":89,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T00:00:00Z","timestamp":1594684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inclusion body myositis is a rare sporadic inflammatory\u2010degenerative myopathy of the elderly. Despite being the commonest type of acquired myopathy after the age of 50, misdiagnosis is extremely common. The most frequent hurdle in identifying new cases is the wrong diagnosis of polymyositis or motor neuron disease. Novel insights into pathogenic mechanisms have heralded the quest for newer therapeutics as well as drug repurposing in this otherwise progressive disorder.<\/jats:p>","DOI":"10.1111\/1756-185x.13902","type":"journal-article","created":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T08:36:02Z","timestamp":1594715762000},"page":"1126-1135","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inclusion body myositis in the rheumatology clinic"],"prefix":"10.1111","volume":"23","author":[{"given":"Anu","family":"Balakrishnan","sequence":"first","affiliation":[{"name":"Department of Clinical Immunology Sanjay Gandhi Postgraduate Institute of Medical Sciences  Lucknow India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology Arthritis and Autoimmunity Center (Falk) UPMC Myositis Center University of Pittsburgh  Pittsburgh Pennsylvania USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology Sanjay Gandhi Postgraduate Institute of Medical Sciences  Lucknow India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology Sanjay Gandhi Postgraduate Institute of Medical Sciences  Lucknow India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,7,14]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","unstructured":"Long\u2010term observational study of sporadic inclusion body myositis | Brain | Oxford Academic [Internet].https:\/\/academic.oup.com\/brain\/article\/134\/11\/3176\/310591. Accessed January 20 2020","DOI":"10.1093\/brain\/awr213"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.02.010"},{"key":"e_1_2_12_4_1","unstructured":"Demographic and clinical features of inclusion body myositis in North America. \u2010 PubMed \u2010 NCBI [Internet].https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25557419. Accessed January 20 2020"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND-160198"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.9.1385"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.8910"},{"key":"e_1_2_12_8_1","unstructured":"(PDF) Writing a narrative biomedical review: Considerations for authors peer reviewers and editors [Internet].https:\/\/www.researchgate.net\/publication\/215575940_Writing_a_narrative_biomedical_review_Considerations_for_authors_peer_reviewers_and_editors. Accessed March 16 2020"},{"key":"e_1_2_12_9_1","unstructured":"MachadoPM.Inclusion body myositis [Internet]. Oxford University Press.https:\/\/oxfordmedicine.com\/view\/10.1093\/med\/9780198754121.001.0001\/med-9780198754121-chapter-11. Accessed February 5 2020."},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr217"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-015-0647-z"},{"key":"e_1_2_12_12_1","unstructured":"Inflammatory Muscle Diseases | NEJM [Internet].https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMra1402225?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed.Accessed February 5 2020"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1309\/LM4Y47NLHQVHSUPX"},{"issue":"6","key":"e_1_2_12_14_1","first-page":"996","article-title":"Pattern of muscle involvement in inclusion body myositis: a sonographic study","volume":"36","author":"Albayda J","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/oti.1325"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780300406"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5069042"},{"issue":"11","key":"e_1_2_12_18_1","first-page":"1628","article-title":"Sporadic inclusion body myositis presenting with severe camptocormia","volume":"20","author":"Ma H","year":"2013","journal-title":"J Clin Neurosci Off J Neurosurg Soc Australas"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2013-000557"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.8.1253"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000101"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2014.12.005"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-015-0541-0"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afj014"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-015-1384-5"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2017.8"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000192259.34541.e4"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206691"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23840"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1181-4"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002960100137"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-012-2556-4"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0715-4"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000431"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-008-0449-0"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2010.03.023"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2013.12.029"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21622"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.4161\/auto.4245"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000192128.13875.1e"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390615"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2008.08.011"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-014-0477-9"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2013.08.007"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12480"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000000642"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.41"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40320"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2019.12.001"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2014.04.001"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.08.009"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4221-z"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004552"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1186\/2051-5960-1-29"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-018-0164-x"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1178"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00456"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22600"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00745"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214644"},{"key":"e_1_2_12_61_1","unstructured":"(PDF) Increased [11C]PIB\u2010PET levels in inclusion body myositis are indicative of amyloid deposition [Internet].https:\/\/www.researchgate.net\/publication\/45820962_Increased_11CPIB-PET_levels_in_inclusion_body_myositis_are_indicative_of_amyloid_deposition. Accessed February 5 2020"},{"key":"e_1_2_12_62_1","unstructured":"Pathogenesis and therapy of inclusion body myositis.https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22941263. Accessed February 5 2020"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22687"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.7.1081"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.3.712"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.5.876"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2019.06.031"},{"key":"e_1_2_12_68_1","unstructured":"Effect of Alemtuzumab (CAMPATH 1\u2010H) in patients with inclusion\u2010body myositis [Internet].https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2685923\/. Accessed February 5 2020"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000192258.32408.54"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.08.007"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30200-5"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.02.015"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.33"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000434671.77891.9a"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.04.007"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-016-3494-3"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00331"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket162"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.02.005"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199307000-00002"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199812)21:12<1724::AID-MUS15>3.0.CO;2-2"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90148-I"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-eular.527"},{"key":"e_1_2_12_84_1","unstructured":"Study of Pioglitazone in Sporadic Inclusion Body Myositis. Full Text View \u2010 ClinicalTrials.gov [Internet].https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03440034. Accessed February 17 2020"},{"key":"e_1_2_12_85_1","unstructured":"Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis. Full Text View \u2010 ClinicalTrials.gov [Internet].https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02481453. Accessed February 17 2020"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.72.5.676"},{"issue":"5","key":"e_1_2_12_87_1","first-page":"841","article-title":"Pilot trial of simvastatin in the treatment of sporadic inclusion\u2010body myositis","volume":"32","author":"Sancricca C","year":"2011","journal-title":"Neurol Sci Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"16","key":"e_1_2_12_88_1","article-title":"A Randomized, double\u2010blind, placebo\u2010controlled study of bimagrumab in patients with sporadic inclusion body myositis (P1.111)","volume":"88","author":"Amato AA","year":"2017","journal-title":"Neurology"},{"key":"e_1_2_12_89_1","unstructured":"Lithium in Inclusion Body Myositis (IBM). Full Text View \u2010 ClinicalTrials.gov [Internet].https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00917956. Accessed February 17 2020"},{"key":"e_1_2_12_90_1","unstructured":"Natalizumab in Inclusion Body Myositis (IBM). Full Text View \u2010 ClinicalTrials.gov [Internet].https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02483845. Accessed Februuary 17 2020"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2F1756-185X.13902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13902","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1756-185X.13902","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185X.13902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T06:01:53Z","timestamp":1692252113000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185X.13902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,14]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1111\/1756-185X.13902"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.13902","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,14]]},"assertion":[{"value":"2020-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}